- Cassava Sciences press release (NASDAQ:SAVA): Q3 GAAP EPS of -$0.58 beats by $0.30.
- $149.0 Million in Cash and Cash Equivalents at September 30, 2024. Expected To Support Operations Into 2026
Cassava Sciences GAAP EPS of -$0.58 beats by $0.30
News / Analytics / Reviews